Aloperine is a quinolizidine alkaloid extracted from the leaves of Sophora plants. It has been recognized with the potential to treat inflammatory and allergic diseases as well as tumors. In this report, we demonstrate that pretreatment with aloperine provided protection for mice against ischemia-reperfusion (IR)-induced acute renal injury as manifested by the attenuated inflammatory infiltration, reduced tubular apoptosis, and well-preserved renal function. Mechanistic studies revealed that aloperine selectively repressed IL-1β and IFN-γ expression by regulating PI3K/Akt/mTOR signaling and NF-κB transcriptional activity. However, aloperine did not show a perceptible impact on IL-6 and TGF-β expression and the related Jak2/Stat3 signaling. It was also noted that aloperine regulates AP-1 activity, through which it not only enhances SOD expression to increase reactive oxygen species (ROS) detoxification but also promotes the expression of antiapoptotic Bcl-2, thereby preventing tubular cells from IR-induced apoptosis. Collectively, our data suggest that administration of aloperine prior to IR insults, such as renal transplantation, could be a viable approach to prevent IR-induced injuries.
of neutrophils, dendritic cells (DCs) and macrophages, followed by the release of copious amounts of inflammatory mediators (18, 19) . Given that tubular cells are very susceptible to ROS (20) (21) (22) , renal tubular apoptosis is a characteristic feature for the progression of IR insult (23) .
Previous studies have consistently demonstrated that aloperine, an alkaloid extracted from sophora alopecuroides, possesses beneficial properties against inflammation, tumor growth and infec tion (24) (25) (26) (27) (28) . As a result, it has been used widely in clinical settings for the treat ment of inflammatory diseases including allergic dermatitis (29) . More interest ingly, recent studies further suggest the potential for aloperine to attenuate oxidative stress (30) . These findings pro mpted us to hypothesize that aloperine could be a good candidate drug for the prevention and treatment of IRinduced acute renal injury. To address this fea sibility, we conducted studies in mice cells, leukocytes, and renal parenchymal cells (7) (8) (9) (10) (11) . Particularly, interplay bet ween inflammatory cytokines/chemo kines, apoptotic factors and reactive oxygen species (ROS) has been observed during the course of IRinduced renal injury (12) (13) (14) (15) . Because of this complex ity, its underlying molecular mechanisms remained poorly understood (16, 17) . It is believed that the innate immune system is activated in the very early stage of IR insult as manifested by the accumulation
INTRODuCTION
Renal ischemia and reperfusion (IR) injury is one of the major causes of acute kidney disease, a disorder with high morbidity and mortality in clin ical settings (1) . Indeed, IR inevitably resulted from the consequences of renal transplantation, aortic bypass surgery, and vascular surgery (2) (3) (4) (5) (6) (34, 35) . Morphological changes in the cor tex and medulla were scored in a blinded fashion by two pathologists according to the severity of tubular necrosis, integrity of brush border and basement membrane, and cast formation. The scoring included 4 scales: 0) <10%; 1) 10% to 25%; 2) 25% to 50%; 3) 50% to 75%; and 4) >75% (36) . Each section was assessed with randomly selected 10 highpower fields (magnifica tion, × 400), and three mice were included in each study group.
Myeloperoxidase (MPO) and F4/80
Immunostaining Renal sections were deparaffinized and treated with proteinase K (Merck). The sections were first treated with 3% H 2 O 2 to block endogenous peroxidase activity, followed by incubation with antibodies against F4/80 antibody (ABD) (Serotec Inc.) and MPO (Thermo Scien tific), respectively. After washes with PBS, the sections were incubated with a biotinylated antirat IgG (ZSJQBIO). The sections were then developed using a Vector stain ABC kit (Vector Labora tories Inc.), and further counterstained with Harris hematoxylin as reported previously (37) . Assessment of neutro phil and macrophage infiltration was carried out in a blinded fashion under a microscope by counting the MPO or F4/80positive cells per field with 10 randomly selected fields per section at magnification of 400×; three mice were examined in each study group.
Real-Time PCR Analysis
Renal total RNA extraction and cDNA synthesis were conducted using the established techniques (38) . Realtime PCR was then carried out using an ABI prism 7500 Sequence Detection System (Applied Biosystems) with primers spe cific for IL-1b (5′GGA TGA GGA CAT  GAG CAC CT3′, 5′GGA GCC TGT  AGT GCA GTT GT3′), IL-10 (5′CCC  TTT GCT ATG GTG TCC TT3′, 5′TGG  TTT CTC TTC CCA AGA CC3′), IFN-g  (5′GGC ACA GTC ATT GAA AGC  CTA3′, 5′CTG CAG GAT TTT CAT (100 IU/mL penicillin, 100 μg/mL strep tomycin) at 37°C under 5% CO 2 for 24 h, then subjected to serum starvation for 24 h by reducing FBS to 2%. After washes, the monolayer was immersed in mineral oil for 3 h, followed by culturing the cells under normal conditions for another 24 h as reported (31, 32) . HK2 and RAW264.7 cultures were divided into four groups: i) normal control (Nor) cells were cul tured under normal condition; ii) hypoxic control (Hypo) cells were subjected to hypoxic insult; iii) hypoxia + aloperine (Hypo + Alo) cells underwent hypoxic insult in the presence of 0.5 mmol/L aloperine; and iv) hypoxia + aloperine + Tanshinone IIA (an inhibitor of for AP1) (Hypo + Alo + TanIIA) cells were sub jected to hypoxia in the presence of aloperine and Tanshinone IIA (TanIIA, 8 μg/mL ).
Induction of Renal IR Injury
The mice were anesthetized by intra peritoneal (IP) injection of 1% pentobar bital (80 mg/kg bodyweight), and then placed in a prone position on a heating pad to maintain their body temperature during surgery. After bilateral flank 1cm incisions, both kidneys were subjected to ischemia for 45 min using microvascular clamps (0.75mm clip width and 5mm jaw length, RoBoz Surgical Instrument Co.) and then reperfused as previously described (33) . All mice were adminis tered 200 μL of saline through subcuta neous injection to maintain fluid balance. After the surgery, the mice had access to food and water ad libitum. Mice were killed 24 h after reperfusion. Plasma samples and renal tissues were collected for experimental purposes.
Assessment of Renal Function
Renal function was assessed by mea suring blood urea nitrogen (BUN) and serum creatinine (Cr) at the Department of Clinical Laboratories of Tongji Hospital.
Histological Analysis
Paraffin embedded renal sections (3 μm) were subjected to hematoxylin and eosin (H&E) and periodic acidSchiff with IR insult. Our results revealed that pretreatment with aloperine provided protection for mice against IRinduced acute renal injury as manifested by the attenuated inflammatory infiltration and reduced tubular apoptosis along with im proved renal function. Our data suggest that administration of aloperine prior to IR insults could be a viable approach to the prevention of IRinduced renal inju ries in clinical settings.
MATERIALS AND METHODS

Animals
Male C57BL/six mice (7 wks old, body weight 2530 g) were purchased from the Animal Experimental Center of Hubei Province (Wuhan, China) and housed in a specific pathogenfree facility with free access to sterile acidified water and irradi ated food. After a minimum acclimation of 1 wk, the mice were randomly allocated into four groups, each containing six mice: i) IRaloperine group (IR + Alo) mice were pretreated with 50 mg/kg bodyweight of aloperine (Q1962, Kmaels) dissolved in saline containing 10% acetic acid (2.5 mg/mL), by gavage for 8 consecutive days before IR insult; ii) I/Rvehicle group (IR) mice were pretreated with 10% acetic acid in normal saline as above followed by IR insult; iii) Sham group (Sham) mice underwent similar surgical procedures but without IR insult; and iv) Shamaloperine group (Sham + Alo) mice were adminis tered with the same dose of aloperine as above. The aloperine dose (50 mg/kg) was optimized by pilot experiments, and no cytotoxicity was observed until the dosage reached 150 mg/kg for 8 We first sought to assess the effect of aloperine pretreatment on IRinduced acute renal injury. For this purpose, the mice were administered with aloperine for 8 consecutive days, followed by IR insult (IR + Alo group) as described. Mice pretreated with vehicle (IR group) or that had undergone similar surgical processes absent of IR insult (Sham group) or Sham mice pretreated with aloperine (Sham + Alo group) served as controls. Sham + Alo mice manifested similar levels of BUN ( Figure 1A ) and Cr ( Figure 1B) as that of Sham mice, indicating that the administration of aloperine did not result in a perceptible change in renal function. As expected, IR insult led to a significant impairment of renal function. However, aloperinepretreated mice displayed a well preserved renal function as mani fested by the significantly lower levels of serum BUN ( Figure 1A ) and Cr ( Figure 1B ) as compared with that of mice from IR group. To confirm these observations, we conducted a histological analysis of renal sections. Indeed, unlike IR + Alo mice, H&E staining revealed that IR mice incurred remarkable tubular injury as evidenced by the severe tubular necrosis, dilation and cast formation ( Figure 1C) . Similarly, PAS staining demonstrated higher severity for loss of brush border and disintegrity of basement membrane in IR mice compared with that of IR + Alo mice ( Figure 1D ). Together, our data support that administration of aloperine provides protection for mice against IRinduced acute renal injury.
Aloperine Pretreatment Attenuates IR-Induced Inflammatory Response
To demonstrate whether the alleviated IR injury in mice from IR + Alo group was due to attenuated inflammatory response, we first examined interstitial used for normalization, and the intensity of each reactive band was analyzed using the den sitometry plugin ImageJ software (http://rsb.info.nih.gov/ij/) as instructed.
Terminal Deoxynucleotidyl Transferase duTP Conjugated with Fluorescein (TuNEL) Assay
Apoptotic cells in renal sections were estimated by TUNEL assay using a kit from Roche Diagnostics using the esta blished techniques (41) . Apoptotic rate was assessed by averaging the total number of apoptotic cells in 10 randomly selected fields at 400 × magnification of each section in a blinded manner. Three sections were examined for each mouse and three mice were included in each study group.
Electrophoretic Mobility Shift Assay (EMSA)
Nuclear proteins derived from HK2 cells and macrophages were prepared using the NEPER Nuclear and Cyto plasmic Extraction Reagents (Thermo Scientific), and then subjected to EMSA using a LightShift Chemiluminescent EMSA Kit (Thermo Scientific) as des cribed previously (34) . Biotinlabeled doublestranded oligonucleotides con taining the NFκbp65 (biotin5′AGT TGA GGG GAC TTT CCC AGG C3′, biotin5′GCC TGG GAA AGT CCC CTC AAC T3′) or AP1 binding site ( biotin5′CGC TTG ATG ACT CAG CCG GAA3′, biotin5′TTC CGG CTG AGT CAT CAA GCG3′) (Beyotime) were used as the probe for analysis of NFκB and AP1 DNA binding activity, respectively. A mixture of unlabeled probes was used as a negative control.
Statistical Analysis
All data are present as mean ± SEM, and all in vitro experiments were con ducted with at least three independent replications. A P value of <0.05 was considered statistically significant. The GraphPad Prism 5 software was employed for statistical analysis using Student t test or oneway or twoway ANOVA where appropriate.
GTC ACC3′), IL-6 (5′AGT TGC CTT CTT GGG ACT GA3′, 5′TCC ACG ATT TCC CAG AGA AC3′), and TGF-b (5′CAA CAA TTC CTG GCG TTA CCT TGG3′, 5′GAA AGC CCT GTA TTC CGT CTC CTT3′). Glyceralhyde3phosphate dehydrogenase (GAPDH) was used for normalization (5′TGG CAT TGT GGA AGG GCT CA3′, 5′GCA CCA GTG GAT GCA GGG AT3′). PCR amplifications were carried out at 95°C for 1 min, fol lowed by 40 cycles at 95°C for 15 sec, 60°C for 1 min. Relative expression levels for each target gene were calculated using the 2 -ΔΔCt approach (38) .
Assays for ROS Accumulation, MDA Level and SOD Activity For analysis of ROS accumulation, fresh frozen sections were incubated with 2′ 7′-dichlorodihydrofluorescein diacetate (DCFHDA, 10 μmol/L, YIJI) at 37°C for 25 min. After washes, the sections were subjected to fluorescence analysis under a fluorescence microscope (Olympus, Japan). The intensity of flu orescence on each section was analyzed using the Image Pro Plus software (Media Cybernetics) as reported (39) . SOD ac tivity and MDA levels were measured by the commercial kits from Nanjing Jiancheng Bioengineering Institute accord ing to their respective instructions.
Western Blot Analysis
Cell or renal lysates (50 μg) were separated on 10% polyacrylamide gel (SigmaAldrich) and transferred onto PVDF membranes. The membranes were blocked with 5% nonfat milk for 1 h and then incubated with antibodies with optimal dilutions against PI3Kp85, pPI3Kp85, AKT, pAKT, mTOR, pmTOR, Bcl2, cFos, Jak2, pJak2, Stat3, pStat3 (all Cell Signaling Technology), GAPDH, lamin B, caspase3 and NFκBp65 (all Santa Cruz Technologies) overnight at 4°C. After six washes (each for 5 min), the membranes were probed with an HRPconjugated secondary antibody and then visualized using an ECL Plus Western blot kit (PIERCE) as reported previously (40) . GAPDH was ( Figure 3B ), but a fourfold increase for IL10 expression was noted in these mice ( Figure 3C ). These results prompted us to examine additional inflammatory cyto kine IL6 and antiinflammatory cytokine TGFβ. Interestingly, IL6 was almost absent in Sham mice, while IR insult induced high levels of IL6 expression in mice from both IR and IR + Alo groups, and particularly, no perceptible effect was noted for aloperine pretreatment in terms of IRinduced IL6 expression ( Figure 3D ). Similarly, IR insult induced high levels of TGFβ expression, but no significant difference was noted between mice originated from the IR and IR + Alo groups ( Figure 3E ). Taken together, initially analyzed inflammatory cytokines IL1β and IFNγ and antiinflammatory cytokine IL10 by realtime PCR. Because no discernable difference was noted bet ween Sham mice and Sham + Alo mice in terms of renal function and inflammatory infiltration, we employed only Sham mice as controls for the following studies. In general, only low levels of IL1β, IFNγ and IL10 were detected in Sham mice. However, IR insult induced a significant upregulation for IL1β ( Figure 3A) and IFNγ ( Figure 3B ), but no perceptible change was noted for IL10 ( Figure 3C ). In sharp contrast, administration of alo perine significantly attenuated IRinduced IL1β ( Figure 3A Similarly, the severity of renal injury was assessed as semiquantitative scores based on the integrity of brush border and basement membrane. Cast formation was assessed as mean ± SEM of six mice analyzed for each group. Scale bar = 100 μm. *, P < 0.05; **, P < 0.01; and ***, P < 0.001.
these results suggest that aloperine pre treatment specifically attenuates IRinduced IL1β and IFNγ production, but potently enhances IL10 secretion to limit inflammatory response following IR insult.
Administration of Aloperine Prevents IR-Induced Tubular Apoptosis
Because tubular apoptosis is a crucial event in IRinduced renal injury and drives the severity of tissue damage (42,43), we next examined the impact of aloperine pretreatment on IRinduced tubular apoptosis by TUNEL assay. TUNELpositive cells were almost absent in the sections of mice from Sham group, while a substantial increase of apoptotic cells was noted in IR mice ( Figure 4A ). However, IR + Alo mice manifested a twofold reduction of apoptotic cells as compared with that IR mice ( Figure 4B ), indicating that aloperine pretreatment prevented IRinduced tubular apoptosis. To confirm this conclusion, we further examined caspase 3 levels by Western Results for quantitative analysis of macrophage infiltration as mean ± SEM of six mice analyzed for each group. Scale bar = 100 μm. *, P < 0.05; **, P < 0.01; and ***, P < 0.001. Figure 3 . Aloperine pretreatment represses inflammatory cytokine production in the kidneys. Real-time PCR was employed to assess the production of inflammatory cytokines. Pretreatment of mice with aloperine significantly repressed IR-induced (A) IL-1β and (B) IFN-γ expression, but enhanced the expression of (C) antiinflammatory cytokine IL-10. Nevertheless, aloperine pretreatment failed to show a significant impact on (D) IL-6 and (E) TGF-β expression although IR insult induced a significant increase for both cytokines. Panels (A-E) present quantitative analysis as mean ± SEM of six mice analyzed for each group. NS: not significant; *, P < 0.05; **, P < 0.01; and ***, P < 0.001.
Aloperine Suppresses PI3K/Akt/mTOR Signaling and NF-jB Activity
To gain insight into the mechanisms underlying aloperine inhibition of IL1β and IFNγ expression, we first examined the activities of MAP kinases ERK1/2 (Supplementary Figure 1A) , p38 (Supple mentary Figure 1B ) and JNK (Supple mentary Figure 1C) by Western blot analysis. Unexpectedly, no differences were detected in terms of total and phos phorylated forms between all experi mental groups 24 h after IR insult, and similar results were obtained at earlier time points such as 6 and 12 h after IR insult (data not shown). These results prompted us to examine the PI3K/Akt/ mTOR signaling. Interestingly, IR insult underlying aloperine attenuation of ROS accumulation, we examined the activity of superoxide dismutase (SOD), a critical enzyme responsible for the detoxification of ROS. Surprisingly, IR insult resulted in a significant reduction of SOD activity, while no discernable change in terms of SOD activity was noted between mice from the Sham and IR + Alo groups ( Figure 5B ), suggesting that aloperine represses ROS accumulation by enhanc ing SOD activity. We then examined the content of lipid peroxidation end product, malondialdehyde (MDA), in the renal lysates, but no perceptible change was noted ( Figure 5C ), suggesting that lipid peroxidation is probably not involved in IRinduced renal injury in our model. blot analysis ( Figure 4C ). Indeed, aloper ine pretreatment resulted in a 1.3fold reduction for caspase 3 as compared with that of IR mice ( Figure 4D ).
Aloperine Pretreatment Reduces IR-Induced ROS Accumulation
Given that oxidative stress caused by ROS accumulation plays a critical role in IRinduced tubular apoptosis (44), we investigated ROS accumulation in renal sections by staining with DCFHDA. It was interestingly noted that IR mice manifested a significant ROS accumu lation as compared with that of Sham mice, while aloperine pretreatment led to a 70% reduction of ROS accumulation ( Figure 5A ). To dissect the mechanism Relative expression levels for caspase 3 by densitometric analysis as mean ± SEM of six mice analyzed for each group. **, P < 0.01; and ***, P < 0.001.
Aloperine Enhances AP-1 Activity to Repress Tubular Apoptosis and to Promote IL-10 Secretion
To explore the mechanism by which aloperine enhances SOD activity to prevent ROS accumulation, we examined AP1 transcriptional activity, a crucial transcrip tion factor responsible for SOD expression. Notably, significantly higher levels of cFos were detected in mice pretreated with aloperine as compared with that in IR and Sham mice ( Figure 7A ), suggesting that aloperine promotes AP1 activity and thereby enhances SOD expression. Because AP1 also transcribes the expression of Bcl2, a critical antiapoptotic molecule (45), we next examined Bcl2 levels in renal lysates. Consistent with enhanced AP1 activity, much higher levels of Bcl2 were detected in aloperinepretreated mice as compared with PBStreated mice (IR group) ( Figure 7B ). described, followed by analysis of NFκB activity. We first conducted Western blot analysis to confirm the effect of aloperine on PI3K/Akt signaling in RAW264.7 cells. Indeed, aloperine significantly atten uated hypoxiainduced PI3Kp85 and Akt activation (Supplementary Figure 1D) . Similarly, treatment of RAW264.7 cells with aloperine markedly inhibited hypoxiainduced NFκB activation as evidenced by the reduced amount of pp65 in the nucleus ( Figure 6E ). To further confirm these data, EMSA was employed to assess NFκB DNA binding activity. It was noted that the addition of aloper ine attenuated hypoxiainduced NFκB DNA binding activity by almost onefold ( Figure 6F ). Collectively, our data sup port that aloperine inhibits PI3K/AkT/ mTOR signaling, thereby repressing NFκB activity to attenuate IL1β and IFNγ expression. significantly induced PI3K activation as manifested by the increase of pPI3Kp85 levels, while aloperine pretreatment sig nificantly attenuated IRinduced PI3K activation ( Figure 6A ). In line with this result, significantly lower activities for its downstream molecules Akt ( Figure 6B ) and mTOR ( Figure 6C ) were noted in aloperinepretreated mice as compared with that of IR mice. Given that NFκB is downstream of PI3K/AkT/mTOR signaling, we further investigated NFκB activation by analysis of phosphorylated p65 (pp65) in the nucleus. As expected, administration of aloperine significantly inhibited NFκB activation as evidenced by the significantly reduced pp65 levels ( Figure 6D) .
To confirm the above results, we cul tured RAW264.7 cells, a murine macro phage cell line, under hypoxic conditions in the presence or absence of aloperine as did not affect IL6 and TGFβ expression. Given the role that Jak2/Stat3 signaling played in the regulation of IL6 and TGFβ transcription (47), we conducted Western blot analysis to check the impact of aloperine on Jak2/Stat3 activity. As expected, IR insult induced a significant increase for total Jak2 and phosphorylated Jak2 (pJak2) (Figure 7G ), and also for total Stat3 and phosphorylated Stat3 (pStat3) ( Figure 7H ). However, we failed to detect a perceptible difference between IR and IR + Alo mice. To confirm this observation, we further examined Jak2/ Stat3 signaling in the aboveprepared RAW264.7 and HK2 cells with hypoxic insult, and similar results were obtained results, significantly higher AP1 DNA binding activity was detected in aloperine treated HK2 cells, which was abrogated by the addition of TanIIA ( Figure 7E ).
Because AP1 also serves as a potent transcription factor for IL10 expression (46), we then treated RAW264.7 cells with aloperine as above in the presence of TanIIA. As expected, aloperine stimulated RAW264.7 cells expression of high levels of IL10, while blockade of AP1 activity by TanIIA almost completely abolished aloperineinduced IL10 expression ( Figure 7F ), indicating that aloperine enhances IL10 expression by regulating AP1 activity. The next important ques tion is why administration of aloperine Next, we cultured HK2 cells, a tubular cell line, under hypoxic conditions as above in the presence of aloperine along with the administration of Tanshinone IIA (TanIIA), an AP1inhibitor. Indeed, hypoxia induced a significant upreg ulation for nuclear cFos ( Figure 7C ) along with enhanced Bcl2 expression ( Figure 7D ) as compared with that of cells cultured under normoxic condition. Importantly, significantly higher levels of cFos ( Figure 7C ) and Bcl2 expression ( Figure 7D) were noted in cells cultured with aloperine as compared with cells without aloperine, while the addition of TanIIA almost completely abolished the effect of aloperine. In line with these proinflammatory cytokine playing a central role in inflammatory responses (49) . By contrast, IL10 possesses antiin flammatory properties in limiting host immune response to pathogens or tissue injury (50) . Consistent with the role both IL1β and IFNγ played during the course of inflammatory responses, IR insult resulted in a significant upregulation of IL1β and IFNγ in the kidneys. However, pretreatment of mice with aloperine mark edly attenuated renal IL1β and IFNγ expression, but the expression of IL10 was increased by fourfold, indicating that alo perine protects mice against IRinduced injury by repressing inflammatory res ponses. Interestingly, unlike its effect on by reperfusion, and IR injury was assessed 24 h after reperfusion. We demon strated convincing evidence suggesting that pretreatment with aloperine provides protection for mice against IRinduced acute renal injury as manifested by the well preserved renal function along with attenuated pathological changes and inflammatory infiltration. Our data sup port that aloperine could be an alterna tive therapy for prevention of IR injury in clinical settings.
IL1β, one of the most important proinflammatory cytokines, is gener ally produced at sites of tissue injury or infection by infiltrated immune cells (48) . Similarly, IFNγ is another potent (data not shown). Collectively, these data suggest that aloperine selectively regulates PI3K/Akt signaling and AP1 activity, but does not affect Jak2/Stat3 signaling and, as a result, administration of aloperine did not result in a significant change for IL6 and TGFβ expression.
DISCuSSION
Although aloperine has been recog nized with therapeutic potential for inflammatory and allergic diseases in clinical settings (28, 29) , its effect on IRinduced acute renal injury, however, has yet to be elucidated. In this study, we induced mice with 45 min ischemia along with aloperine precondition followed next examined the impact of aloperine on IRinduced ROS accumulation. As expected, IR insult induced a significant accumulation of ROS in the kidneys. However, pretreatment of mice with aloperine significantly prevented ROS accumulation as manifested by the re duction of fluorescence intensity. We then checked SOD activity, a critical en zyme responsible for the detoxification of ROS. It was noted that mice that had undergone IR insult manifested a signif icant reduction of SOD activity, while pretreatment of mice with aloperine al most completely prevented IRinduced suppression of SOD activity, suggesting that IRinduced ROS accumulation is at least in part caused by the impaired capability for ROS detoxification. Nev ertheless, lipid peroxidation is unlikely involved in the induction of oxidative stress in our model as no difference was noted for MDA between all groups of mice. Of important note, in contrast to our observations in IRinduced acute renal injury, a previous study suggested that aloperine was able to reduce the content of MDA in hepatic tissue of intoxicated animals without affecting SOD activity (28) . This discrepancy might be due to the differences of ani mal models employed.
To further address the mechanisms relevant to enhanced SOD activity and repressed tubular apoptosis, we checked AP1 activity as it is a crucial factor responsible for SOD expression and antiapoptotic Bcl2 transcription (45, 67) . Excitingly, renal lysates originated from aloperinepretreated mice displayed a significant increase for nuclear AP1 subunit cFos along with enhanced Bcl2 expression. To confirm those results, we further examined HK2 lysates that had undergone hypoxic insult. Indeed, the addition of aloperine significantly enhanced hypoxiainduced nuclear cFos and antiapoptotic Bcl2 expression, which was completely abrogated by the addition of TanIIA, an AP1 inhibitor. Collectively, our data support that aloperine regulates AP1 activity, by which it enhances SOD expression injury (62, 63) . However, we cannot exclude the feasibility that aloperine regu lates additional pathways other than the PI3K/Akt/mTOR signaling in the setting of IRinduced acute renal injury. In addition, the detailed mecha nisms underlying aloperine repression of PI3K signaling remain to be elucidated and would be a major focus for future studies. It is worth noting that aloperine did not regulate Jak2/Stat3 signaling, a critical pathway for IL6 and TGFβ tran scription, and, therefore, IL6 and TGFβ expression were not affected following aloperine treatment. However, previous studies also suggested that the transcrip tion of IL6 can be regulated by NFκB as well (64) . The confliction between our current report and previous stud ies could be caused by the differences in experimental system and cell types. Also, our data could be a consequence of interplay between NFκB and Jak2/Stat3 signaling.
Programmed death of tubular cells is another critical characteristic feature relevant to IRinduced acute renal injury (65) . Indeed, IR insult rendered tubular cells undergoing apoptosis along with upregulation of caspase3. However, pretreatment of mice with aloperine prevented tubular cells from IRinduced apoptosis as evidenced by the significant reduction of TUNELpositive tubular cells and decreased protein levels for caspase3. This finding somehow is in conflict with studies in tumor cells in which aloperine was noted to promote cancer or tumor cell apoptosis (26, 66) . To confirm this observation, we cultured HK2 cells under hypoxic conditions in the presence of aloperine and similar results were obtained (data not shown). In the setting of cancer therapy, high doses of aloperine were employed to generate cytotoxicity for killing tumor cells, and therefore, it is likely that this discrepancy was caused by the differ ences of aloperine doses.
Given that oxidative stress caused by a burst of ROS generation and a decrease of antioxidants is a critical feature in IRinduced tubular apoptosis (44), we IL1β and IFNγ, we failed to obtain data supporting that aloperine modulates IL6 and TGFβ expression.
The mechanisms underlying IRinduced acute renal injury are complex and have yet to be fully elucidated. However, MAP kinases and PI3K/Akt/mTOR sig naling are thought to be implicated in the initiation and progression of IRinduced inflammatory responses (51) (52) (53) (54) . We first examined the impact of aloperine on MAP kinase activities. Unexpectedly, we failed to detect a perceptible change in terms of the expression for total and activated (phosphorylated) ERK1/2, p38 and JNK, suggesting that MAP kinases are not relevant to an aloperinemediated protective effect in our model. These re sults prompted us to embark on the PI3K/ Akt/mTOR signaling, which is well known to regulate a variety of essential cellular functions ranging from glucose metabolism, protein synthesis, cell proliferation, apoptosis and survival (55) (56) (57) (58) . PI3K consists of two elements, the regulatory subunit p85 and the cat alytic subunit p110 (22, 59) . Its function relies on the activation of p85. Unlike its effect on MAP kinases, mice pretreated with aloperine manifested significantly attenuated levels for phosphorylated PI3Kp85, Akt and mTOR, while total PI3Kp85, Akt and mTOR were not changed. In line with these results, the phosphorylated levels for NFκBp65 in the nucleus were reduced significantly in aloperinepretreated mice as com pared with that of IR mice. Indeed, RAW264.7 cells cultured under hypoxic conditions in the presence of aloperine manifested attenuated PI3K/Akt/mTOR signaling, which then repressed the acti vation of NFκBp65 along with reduced DNA activity. In looking at this data to gether, our results suggest that aloperine atten uates inflammatory responses in the setting of IRinduced acute renal injury by repressing PI3K/Akt/mTOR signaling and NFκB transcriptional activity. In sup port of this conclusion, PI3K/Akt/mTOR signaling has already been recognized to play a crucial role in inflammatory infil tration (60, 61) and IRinduced cardiac to promote ROS detoxification along with an increase of antiapoptotic Bcl2 expression, thereby protecting tubular cells from IRinduced apoptosis. Inter estingly, blockade of AP1 activity in RAW264.7 cells by the addition of TanIIA almost completely abolished aloper ineinduced IL10 expression, indicating that aloperine promotes IL10 expression by enhancing AP1 activity as well. Of important note, PI3K/Akt signaling has been suggested to serve as a survival sig nal during renal IR (68) and, as a result, aloperine protection of IRinduced tubu lar apoptosis could be a compromised effect from the homeostasis of multiple signaling pathways.
CONCLuSION
In summary, we demonstrated con vincing evidence that pretreatment of mice with aloperine provides protection against IRinduced acute renal injury as manifested by the attenuated inflamma tory infiltration, reduced tubular apop tosis along with well preserved renal function. Mechanistic studies revealed that aloperine selectively represses IL1β and IFNγ expression by regulating PI3K/Akt/mTOR signaling and NFκB transcriptional activity. Aloperine also regulates AP1 activity, through which it not only enhances SOD and antiapoptotic Bcl2 expression to prevent tubular cells from IRinduced apoptosis, but also pro motes IL10 expression to limit inflamma tory response. Together, our data support that the administration of aloperine prior to IR insults such as renal transplantation could be a viable approach to prevent IRinduced injuries in clinical settings.
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